FLUOGUIDE A/S DK -1
Research FLUOGUIDE A/S DK -1 (96X) on Bullrun: market cap EUR 57.55M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker96X
- ExchangeF
- CountryDenmark
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 57.55M
- Financial periodQ4 2025
- Net income-EUR 13.09M
- Free cash flow-EUR 5.03M
Valuation Snapshot
latest market cap is EUR 57.55M.
About FLUOGUIDE A/S DK -1
FluoGuide A/S, a clinical stage biotechnology company, develops drugs for precision cancer surgery in Denmark. The company offers FG001, an urokinase-type plasminogen activator receptor target imaging agent, which is in Phase II clinical trial for the treatment of high-grade glioma and lung, head, and neck cancer; and functions as a photosensitizer, which is in pre-clinical stage for the treatment of brain cancer through photothermal and photodynamic therapies.
Frequently asked questions
What is FLUOGUIDE A/S DK -1's market cap?
FLUOGUIDE A/S DK -1's market capitalization is EUR 57.55M.
What does FLUOGUIDE A/S DK -1 do?
FluoGuide A/S, a clinical stage biotechnology company, develops drugs for precision cancer surgery in Denmark. The company offers FG001, an urokinase-type plasminogen activator receptor target imaging agent, which is in Phase II clinical trial for the treatment of high-grade glioma and lung, head,...